References
- Nishihara T, Koseki T. (2004). Microbial etiology of periodontitis. Periodontol 2000, 36:14–26.
- Ezzo PJ, Cutler CW. (2003). Microorganisms as risk indicators for periodontal disease. Periodontol 2000, 32:24–35.
- O’Keefe EJ, Chiu ML, Payne RE Jr. (1988). Stimulation of growth of keratinocytes by basic fibroblast growth factor. J Invest Dermatol, 90:767–769.
- Montesano R, Vassalli JD, Baird A, Guillemin R, Orci L. (1986). Basic fibroblast growth factor induces angiogenesis in vitro. Proc Natl Acad Sci USA, 83:7297–7301.
- Takayama S, Murakami S, Miki Y, Ikezawa K, Tasaka S, Terashima A et al. (1997). Effects of basic fibroblast growth factor on human periodontal ligament cells. J Periodont Res, 32:667–675.
- Sato Y, Watanabe N, Ohkuma M, Danjo K. (2009). Design of drug formulation required for periodontal disease. Journal of Pharmaceutical Science and Technology, Japan, 69:392–398.
- Sato Y, Oba T, Natori N, Danjo K. (2010). Evaluation of additives required for periodontal disease formulation using basic fibroblast growth factor. Chem Pharm Bull, 58:1582–1586.
- Kawasaki Y, Matsuka N, Okada T, Kawashima R, Kitagawa N, Sendo T, Gomita Y. (2008). Examination of particulate contamination after opening ampoules–Relationship between ampoule inner-diameter and glass particle accumulation after opening ampoules–Jpn. J Pharm Health Care Sci, 34:1032–1036.
- Zacher AN, Zornow MH, Evans G. (1991). Drug contamination from opening glass ampules. Anesthesiology, 75:893–895.
- Shelmet J, Schwartz S, Cappleman J, Peterson G, Skovlund S, Lytzen L et al.; InnoLet Study Group. (2004). Preference and resource utilization in elderly patients: InnoLet versus vial/syringe. Diabetes Res Clin Pract, 63:27–35.
- Summers KH, Szeinbach SL, Lenox SM. (2004). Preference for insulin delivery systems among current insulin users and nonusers. Clin Ther, 26:1498–1505.